Related Experiment Video
Updated: Aug 10, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Evidence for lipid peroxidation in obstructive sleep apnea
Lena Lavie1, Alona Vishnevsky, Peretz Lavie
1The Lloyd Rigler Sleep Apnea Research Laboratory, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. lenal@tx.technion.ac.il
Obstructive sleep apnea (OSA) increases oxidative stress, indicated by higher lipid peroxidation biomarkers. Treatment with nasal continuous positive airway pressure (nCPAP) effectively reduces these markers, suggesting a link between OSA, oxidative stress, and cardiovascular disease.
Area of Science:
- Cardiology
- Sleep Medicine
- Biochemistry
Background:
- Obstructive sleep apnea syndrome (OSA) is linked to increased cardiovascular morbidity.
- Oxidative stress is a proposed mechanism underlying this association.
Purpose of the Study:
- To investigate lipid peroxidation biomarkers in OSA patients compared to controls.
- To assess the impact of nasal continuous positive airway pressure (nCPAP) treatment on these biomarkers.
Main Methods:
- Experiment 1: Measured plasma thiobarbituric reactive substances (TBARS), peroxides (PD), and paraoxonase-1 (PON1) in OSA patients (with/without cardiovascular disease) and controls.
- Correlated biomarker levels with respiratory disturbance index (RDI).
- Experiment 2: Measured nocturnal TBARS and PD in OSA patients before and after nCPAP treatment, and in controls.
Main Results:
- OSA patients exhibited significantly higher morning TBARS and PD levels than controls.
- Lower PON1 levels were observed in OSA patients with cardiovascular disease.
- TBARS and PD positively correlated with RDI; PON1 negatively correlated with RDI.
- Nocturnal TBARS and PD were reduced by nCPAP treatment in OSA patients.
Conclusions:
- Findings support elevated oxidative stress in OSA.
- Results suggest OSA's potential role in cardiovascular morbidity.
- nCPAP treatment may mitigate oxidative stress associated with OSA.
Related Concept Videos
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration can...
Chronic Obstructive Pulmonary Disease II: Emphysema

